Published in Front Cell Infect Microbiol on July 19, 2017
A research agenda to underpin malaria eradication. PLoS Med (2011) 5.34
Primaquine therapy for malaria. Clin Infect Dis (2004) 4.66
Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science (2006) 4.35
Antiretrovirals as antimalarial agents. J Infect Dis (2004) 3.60
Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet (2005) 3.48
The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol (2006) 2.83
Primaquine revisited six decades after its discovery. Eur J Med Chem (2008) 2.43
Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging. PLoS One (2009) 2.18
HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS (2004) 2.12
Consequences of HIV infection on malaria and therapeutic implications: a systematic review. Lancet Infect Dis (2011) 2.01
Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. J Infect Dis (2005) 1.88
Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin Infect Dis (2005) 1.81
Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrob Agents Chemother (2006) 1.72
Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS (2006) 1.71
Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. N Engl J Med (2012) 1.58
Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry. Cell Microbiol (2007) 1.50
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds. Proc Natl Acad Sci U S A (2012) 1.31
Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum. Antimicrob Agents Chemother (2008) 1.26
HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites. J Infect Dis (2009) 1.24
Antimalarial activity of sera from subjects taking HIV protease inhibitors. AIDS (2007) 1.23
HIV and malaria co-infection: interactions and consequences of chemotherapy. Trends Parasitol (2008) 1.17
A toolbox to study liver stage malaria. Trends Parasitol (2011) 1.16
In vitro activity of antiretroviral drugs against Plasmodium falciparum. Antimicrob Agents Chemother (2011) 1.16
Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells. Br J Pharmacol (2010) 1.09
Etravirine, a next-generation nonnucleoside reverse-transcriptase inhibitor. Clin Infect Dis (2009) 1.09
New active drugs against liver stages of Plasmodium predicted by molecular topology. Antimicrob Agents Chemother (2008) 1.01
HIV treatments have malaria gametocyte killing and transmission blocking activity. J Infect Dis (2013) 0.99
Interactions between malaria and human immunodeficiency virus anno 2014. Clin Microbiol Infect (2014) 0.99
HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit plasmodium liver stages. J Infect Dis (2012) 0.96
Targeting the liver stage of malaria parasites: a yet unmet goal. J Med Chem (2011) 0.96
Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir. AIDS (2010) 0.94
Antiretroviral therapy: current drugs. Infect Dis Clin North Am (2014) 0.94
The activity and inhibition of the food vacuole plasmepsin from the rodent malaria parasite Plasmodium chabaudi. Acta Trop (2005) 0.93
The effect of antiretrovirals on Plasmodium falciparum liver stages. AIDS (2013) 0.88
The combined anti-HIV-1 activities of emtricitabine and tenofovir plus the integrase inhibitor elvitegravir or raltegravir show high levels of synergy in vitro. Antimicrob Agents Chemother (2014) 0.84
HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo. PLoS One (2014) 0.84
The prevalence of malaria in people living with HIV in Yaounde, Cameroon. BMC Public Health (2016) 0.80
GLUT1-mediated glucose uptake plays a crucial role during Plasmodium hepatic infection. Cell Microbiol (2016) 0.79
Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa. Curr Drug Metab (2011) 0.79
Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis. Malar J (2011) 0.78
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning. PLoS One (2015) 0.78
Inhibition of Plasmodium liver infection by ivermectin. Antimicrob Agents Chemother (2016) 0.77
Buy one, get one free? Benefits of certain antiretrovirals against malaria. AIDS (2016) 0.76
The effect of lopinavir/ritonavir on the antimalarial activity of artemether or artemether/lumefantrine in a mouse model of Plasmodium berghei. J Chemother (2014) 0.76
Repurposing strategies for tropical disease drug discovery. Bioorg Med Chem Lett (2016) 0.76
Antimalaria action of antiretroviral drugs on Plasmodium berghei in mice. Am J Trop Med Hyg (2012) 0.75
Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults. AIDS (2017) 0.75